Abattis Bioceuticals Market Cap

Abattis Bioceuticals has a market cap or net worth of $476.00 as of June 9, 2025.

Market Cap

476.00

Enterprise Value

n/a

Revenue

269.58K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since September 19, 2012, Abattis Bioceuticals's market cap has decreased from 1.46M to 476.00, a decrease of -99.97%. That is a compound annual growth rate of -46.93%.

Market Cap History

Date	Market Cap	% Change
May 19, 2025	476.00	-
Dec 30, 2024	476.00	-
Dec 29, 2023	476.00	-
Dec 30, 2022	476.00	-
Dec 31, 2021	476.00	-99.99%
Dec 31, 2020	5.95M	177.78%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.66B
Veradigm	747.25M
Nika Pharmaceuticals	666.65M
Tian'an Technology Group	637.25M
Elite Pharmaceuticals	619.60M
Glass House Brands	444.40M
CytoDyn	437.04M
Northwest Biotherapeutics	391.68M

Market Cap Rankings